Although these adverse events of blood clotting appear to be extremely rare, safety of the COVID-19 vaccine is a top priority for the federal government.” Kahele added. If you have received the J&J vaccine and develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination, please contact your health care provider. According to the New York Times, United States health regulators ended the pause on the single dose shot on Friday. 7 million doses have been administered in total, and all of the reported blood clot side effects occurred in women between. In response to this, the CDC and FDA have decided to recommend a pause in the administration of the vaccine. “In Hawaiʻi, the J&J vaccine has been widely used in recent weeks due to the convenience of a single shot dose. The Johnson & Johnson COVID-19 vaccine has been approved for use, once again. A number of rare and severe blood clots have been reported after receiving the Johnson & Johnson COVID-19 vaccine.

Although six reported cases out of 6.8 million vaccine recipients represents an extremely small number, until we have more information, I fully support the CDC and FDA’s decision to put the J&J vaccine on pause out of an abundance of caution,” said Kahele. As of April 12, more than 6.8 million doses of the J&J vaccine have been administered in the United States. “My staff and I are closely monitoring reports that six recipients of the Johnson & Johnson vaccine in the United States have developed cases of a ‘rare and severe’ type of blood clot. Food and Drug Administration’s recommendation to pause the use of Johnson & Johnson’s COVID-19 vaccine following reports of six cases of a “rare and severe” type of blood clot. Centers for Disease Control and Prevention and the U.S. REMOTE, (April 13, 2021): In response to the joint CDC and FDA announcement and out of an abundance of caution, today the Colorado Department of Public Health and Environment (CDPHE) and the Colorado Joint Vaccine Task Force are alerting providers to temporarily pause use of the Johnson & Johnson (Janssen) COVID-19 vaccine. Congressman Kaialiʻi Kahele (HI-02) issued the following statement today in response to the U.S.

Cdc pauses johnson and johnson vaccine